At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Initial Evaluation of the Safety and Performance of the Transcatheter Mitral Intrepid Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation
In Brief
A clinical study evaluating Twelve TMVR Implant and Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System for Mitral Valve Insufficiency. Active but no longer recruiting, targeting 128 participants across 32 sites in 7 countries.
Detailed Summary
PILOT: The study is a pilot trial to evaluate the safety and performance of the Twelve TMVR System in high risk mitral regurgitation patients. EFS: The study is an Early Feasibility Study to evaluate the safety and performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in Patients with moderate-Severe or severe, Symptomatic Mitral Regurgitation
Study Details
Timeline
Interventions
Implantation of the Twelve TMVR System - Apical
Implantation of the Medtronic Intrepid™ Transcatheter Mitral Valve- Transfemoral